At a glance
ClinicalIndex Comparison RecordN/ACompleted· 720 enrolled
Drug / intervention
Integrated care van (ICV)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Building on Needle Exchange to Optimize Prevention & Treatment
In Brief
A clinical study evaluating Integrated care van (ICV) for Intravenous Drug Usage and HIV/AIDS. Completed, enrolled 720 participants across 1 site.
Detailed Summary
There are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID by an integrated care van that is linked to a mobile syringe service program improves clinical outcomes, is feasible and sustainable, and is cost-effective.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntravenous Drug Usage, HIV/AIDS
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJun 2018
Primary CompletionMar 2020
Study CompletionAug 2022
TodayJul 2026
First PostedJun 25, 2018
Enrollment StartJun 22, 2018
Primary CompletionMar 12, 2020
Study CompletionAug 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.0 years ago
Interventions
Integrated care van (ICV)other
Structural service delivery intervention